Peter Staehr

Peter Staehr, M.D., is an experienced medical professional currently serving as the Chief Medical Officer - Consultant at Origenis GmbH, where leadership is provided for Clinical Development and Business Strategy related to innovative small molecule drug pipelines. Peter holds the position of Chairman for the Pharmaceutical & BioScience Society in the San Francisco Bay Area, contributing to a prominent organization with over 5,000 members in the life sciences. Previous roles include Vice President of Clinical Development and Translational Medicine at ChemoCentryx and Senior Director at Abbott Vascular Inc., with extensive experience in global clinical development across multiple therapeutic areas, including rare diseases and oncology. Peter’s academic background includes a medical degree from Johannes Gutenberg University Mainz and a fellowship in Internal Medicine and Cardiology at Mainz University Medical Center.